The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Multiple Genetic Loci for Bone Mineral Density and Fractures
Open accessAbstract
BACKGROUND: Bone mineral density influences the risk of osteoporosis later in life and is useful in the evaluation of the risk of fracture. We aimed to identify sequence variants associated with bone mineral density and fracture. METHODS: We performed a quantitative trait analysis of data from 5861 Icelandic subjects (the discovery set), testing for an association between 301,019 single-nucleotide polymorphisms (SNPs) and bone mineral density of the hip and lumbar spine. We then tested for an association between 74 SNPs (most of which were implicated in the discovery set) at 32 loci in replication sets of Icelandic, Danish, and Australian subjects (4165, 2269, and 1491 subjects, respectively). RESULTS: Sequence variants in five genomic regions were significantly associated with bone mineral density in the discovery set and were confirmed in the replication sets (combined P values, 1.2x10(-7) to 2.0x10(-21)). Three regions are close to or within genes previously shown to be important to the biologic characteristics of bone: the receptor activator of nuclear factor-kappaB ligand gene (RANKL) (chromosomal location, 13q14), the osteoprotegerin gene (OPG) (8q24), and the estrogen receptor 1 gene (ESR1) (6q25). The two other regions are close to the zinc finger and BTB domain containing 40 gene (ZBTB40) (1p36) and the major histocompatibility complex region (6p21). The 1p36, 8q24, and 6p21 loci were also associated with osteoporotic fractures, as were loci at 18q21, close to the receptor activator of the nuclear factor-kappaB gene (RANK), and loci at 2p16 and 11p11. CONCLUSIONS: We have discovered common sequence variants that are consistently associated with bone mineral density and with low-trauma fractures in three populations of European descent. Although these variants alone are not clinically useful in the prediction of risk to the individual person, they provide insight into the biochemical pathways underlying osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Self-citationEpidemiology and outcomes of osteoporotic fractures
Cummings, S. R., & Melton, L. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08657-9 · Cited by 3,821
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
Predictive Value of BMD for Hip and Other Fractures
Johnell, O., Kanis, J. A., Oden, A., Johansson, H., De Laet, C., Delmas, P., Eisman, J. A., Fujiwara, S., Kroger, H., Mellstrom, D., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050304 · Cited by 1,445
Self-citationKanis, J. A., Oden, A., Johnell, O., Johansson, H., De Laet, C., Brown, J., Burckhardt, P., Cooper, C., Christiansen, C., Cummings, S., et al. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0343-y · Cited by 1,224
Self-citationKearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9788 · Cited by 746
Peacock, M., Turner, C. H., Econs, M. J., & Foroud, T. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0464 · Cited by 468
Genetic regulation of bone mass and susceptibility to osteoporosis
Ralston, S. H., & de Crombrugghe, B. (2006) · Genes & Development · doi:10.1101/gad.1449506 · Cited by 364
Ioannidis, J. P. A. (2004) · JAMA · doi:10.1001/jama.292.17.2105 · Cited by 297
Genome-wide association with bone mass and geometry in the Framingham Heart Study
Kiel, D. P., Demissie, S., Dupuis, J., Lunetta, K. L., Murabito, J. M., & Karasik, D. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s14 · Cited by 269
Minireview: Genomic Organization of the Human ERα Gene Promoter Region
Koš, M., Reid, G., Denger, S., & Gannon, F. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0731 · Cited by 267
Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review
Gennari, L. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi055 · Cited by 243
Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures
Langdahl, B. L., Carstens, M., Stenkjaer, L., & Eriksen, E. F. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1245 · Cited by 191
Bagger, Y. Z., Rasmussen, H. B., Alexandersen, P., Werge, T. M., Christiansen, C., Tankó, L. B., & PERF study group (2006) · Osteoporosis International · doi:10.1007/s00198-006-0255-2 · Cited by 144
Self-citationYamada, T., Yamazaki, H., Yamane, T., Yoshino, M., Okuyama, H., Tsuneto, M., Kurino, T., Hayashi, S., & Sakano, S. (2003) · Blood · doi:10.1182/blood-2002-06-1740 · Cited by 124
Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?
Tankó, L. B., Bagger, Y. Z., Nielsen, S. B., & Christiansen, C. (2003) · Bone · doi:10.1016/s8756-3282(02)00918-3 · Cited by 117
Self-citationFunctional Dissection of Osteoprotegerin and Its Interaction with Receptor Activator of NF-κB Ligand
Schneeweis, L. A., Willard, D., & Milla, M. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506366200 · Cited by 116
Multiple prostate cancer risk variants on 8q24
Witte, J. S. (2007) · Nature Genetics · doi:10.1038/ng0507-579 · Cited by 115
Hsu, Y., Niu, T., Terwedow, H. A., Xu, X. P., Feng, Y., Li, Z., Brain, J. D., Rosen, C. J., Laird, N. M., & Xu, X. (2005) · Human Genetics · doi:10.1007/s00439-005-0062-4 · Cited by 115
Nguyen, T. V., Sambrook, P. N., & Eisman, J. A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.124 · Cited by 110
Self-citationKim, J. G., Kim, J. H., Kim, J. Y., Ku, S., Jee, B. C., Suh, C. S., Kim, S. H., & Choi, Y. M. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31802d976f · Cited by 109
Minireview: Genomic Organization of the Human ER Gene Promoter Region
Koš, M. (2001) · Molecular Endocrinology · doi:10.1210/me.15.12.2057 · Cited by 109
J�rgensen, H. L., Kusk, P., Madsen, B., Fenger, M., & Lauritzen, J. B. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0461-3 · Cited by 85
A novel endonuclease IV post-PCR genotyping system
Kutyavin, I. V., Milesi, D., Belousov, Y. S., Podyminogin, M. A., Vorobiev, A. A., Gorn, V. V., Lukhtanov, E. A., Vermeulen, N. M. J., & Mahoney, W. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl679 · Cited by 84
Zhao, H., Liu, J., Ning, G., Zhao, Y., Zhang, L., Sun, L., Xu, M.-Y., Uitterlinden, A. G., & Chen, J. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1865-9 · Cited by 80
Albagha, O., Pettersson, U., Stewart, A., McGuigan, F. E. A., MacDonald, H. M., Reid, D. M., & Ralston, S. H. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.023895 · Cited by 78
Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal Women
Choi, J. Y., Shin, A., Park, S., Chung, H. W., Cho, S. I., Shin, C. S., Kim, H., Lee, K., Lee, K., Kang, C., et al. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0264-0 · Cited by 71
Wynne, F., Drummond, F. J., O’Sullivan, K., Daly, M., Shanahan, F., Molloy, M. G., & Quane, K. A. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-2081-z · Cited by 69
Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis
Ohmori, H., Makita, Y., Funamizu, M., Hirooka, K., Hosoi, T., Orimo, H., Suzuki, T., Ikari, K., Nakajima, T., Inoue, I., et al. (2002) · Journal of Human Genetics · doi:10.1007/s100380200058 · Cited by 68
Ueland, T., Bollerslev, J., Wilson, S. G., Dick, I. M., Islam, A. F. M., Mullin, B. H., Devine, A., & Prince, R. L. (2006) · Bone · doi:10.1016/j.bone.2006.06.022 · Cited by 68
Brändström, H., Gerdhem, P., Stiger, F., Obrant, K. J., Melhus, H., Ljunggren, Ö., Kindmark, A., & Åkesson, K. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2136-9 · Cited by 53
Meta-analysis of genome-wide linkage studies for bone mineral density
Lee, Y. H., Rho, Y. H., Choi, S. J., Ji, J. D., & Song, G. G. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0390-9 · Cited by 46
Albagha, O., & Ralston, S. H. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.08.001 · Cited by 44
Genetic and environmental determinants of osteoporosis.
Kung, A. W. C., & Huang, Q. (2007) · PubMed · Cited by 41
Lei, S., Jiang, H., Deng, F., & Deng, H. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0402-4 · Cited by 28
Cited by
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y.-H., Duncan, E. L., Ntzani, E. E., Oei, L., Albagha, O. M. E., Amin, N., Kemp, J. P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2249 · Cited by 1,174
Self-citationCho, Y. S., Go, M. J., Kim, Y. J., Heo, J. Y., Oh, J. H., Ban, H.-J., Yoon, D., Lee, M. H., Kim, D.-J., Park, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.357 · Cited by 1,015
Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., Handunnetthi, L., Handel, A. E., Disanto, G., Orton, S.-M., et al. (2010) · Genome Research · doi:10.1101/gr.107920.110 · Cited by 873
the Genetic Factors for Osteoporosis (GEFOS) Consortium (2009) · Nature Genetics · doi:10.1038/ng.446 · Cited by 706
Metadata
- Authors
- Styrkarsdottir, U., Halldorsson, B. V., Gretarsdottir, S., Gudbjartsson, D. F., Walters, G. B., Ingvarsson, T., Jonsdottir, T., Saemundsdottir, J., Center, J. R., Nguyen, T. V., Bagger, Y., Gulcher, J. R., Eisman, J. A., Christiansen, C., Sigurdsson, G., Kong, A., Thorsteinsdottir, U., & Stefansson, K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-29
- Volume
- 358
- Issue
- 22
- Pages
- 2355-2365
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1972354950
- Cited by
- 629
- References
- 41
- FWCI
- 69.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.